noscript

News and Announcements

AIMEDICS Announces UK HypoMon Product Release

  • Published June 20, 2012 2:42PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

New hypo alarm to give young people with type 1 diabetes a safer night’s sleep. For the first time young people with type 1 diabetes have the opportunity for a safer night’s sleep with the world’s most rigorously tested non-invasive nocturnal hypo alarm system, the HypoMon®.

After a decade in development by AIMEDICS, the ground breaking HypoMon is being release via key diabetes hospitals in the UK for use by people with type 1 diabetes aged between 10 and 25 years. Its release follows clinical trials showing that the simple and easy-to-use HypoMon accurately identifies more sleep-time hypoglycaemia (hypos) than other continuous monitoring systems currently available.

—–

To view the full article, please click the link below.

 

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now